Jane Street
ANIP icon

Jane Street’s ANI Pharmaceuticals ANIP Stock Holding History

Jane Street’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$369K Sell
4,800
-13,200
-73% -$1.03M ﹤0.01% 8758
2025
Q4 		$1.42M Buy
18,000
+11,500
+177% +$996K ﹤0.01% 5422
2025
Q3 		$595K Buy
+6,500
New +$530K ﹤0.01% 7471
2023
Q3 		– Sell
-6,300
Closed -$339K – 8568
2023
Q2 		$339K Buy
+6,300
New +$279K ﹤0.01% 6926
2016
Q2 		– Sell
-15,000
Closed -$505K – 4023
2016
Q1 		$505K Buy
15,000
+5,800
+63% +$197K ﹤0.01% 2596
2015
Q4 		$415K Buy
+9,200
New +$396K ﹤0.01% 2700

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jane Street's ANIP Position: Q1 2026 in Review

Jane Street sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 25,657 shares — an estimated $2M sold.

Jane Street first reported a position in ANIP in Q1 2014 and held it in 18 quarters. The position peaked at $12.3M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Jane Street reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 25,657 ANI Pharmaceuticals shares in Q1 2026, an estimated $2M.
  • Jane Street first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 18 quarters.
  • Jane Street's ANI Pharmaceuticals position peaked at $12.3M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.